MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi - 02/09/11
Abstract |
Background: The histopathologic differential diagnosis of Spitz nevus (SN) from malignant melanoma (MM) may be difficult. Objective: Our purpose was to determine the staining pattern and usefulness of MIB-1 antibody, which recognizes Ki-67 antigen in formalin-fixed, paraffin-embedded tissue, as an adjunct to the histopathologic differential diagnosis of SN. Methods: Twenty-five compound SNs, 27 MMs, and 26 compound nondysplastic melanocytic nevi (MNs) were immunostained with the MIB-1 antibody. Results: The mean counts of MIB-1-stained tumor cells of the epidermal and dermal components, both alone and together, were significantly lower in SNs and MNs than in MMs (P < .0001). The dermal counts showed the best discriminating power. In addition, the mean dermal/epidermal count ratios for MIB-1 in SNs and MNs (0.25 and 0.23, respectively) were significantly lower than the corresponding ratio (0.94) in MMs (P < .0001). Conclusion: MIB-1-stained tumor cell counts, especially of the dermal component, and dermal/epidermal MIB-1 count ratios may be helpful as an adjunct to the histopathologic differential diagnosis of SN. (J Am Acad Dermatol 2001;44:500-4.)
Le texte complet de cet article est disponible en PDF.Abbreviations : MM, MN, PCNA, SN
Plan
 | Reprint requests: Reuven Bergman, MD, Head, Department of Dermatology, Rambam Medical Center, POB 9602, 31096 Haifa, Israel. E-mail: dermatology@rambam.health.gov.il. |
Vol 44 - N° 3
P. 500-504 - mars 2001 Retour au numéro
Article précédent
- Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery
- Malcolm Schinstine, Glenn D. Goldman
- American Academy of Dermatology Consensus Conference on UVA protection of sunscreens: Summary and recommendations : Washington, DC, Feb 4, 2000
- Henry W. Lim, Mark Naylor, Herbert Hönigsmann, Barbara A. Gilchrest, Kevin Cooper, Warwick Morison, Vincent A. DeLeo, Lubomira Scherschun
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?